Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 2Sexual Infantilism 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Inflammation 1Hypothalamic Neoplasms 1Dyslipidemias 1Craniopharyngioma 1

Interventions

Metformin 7Testosterone 2Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2Blood Pressure 2semaglutide 1maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Walking 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Topiramate 1Tirzepatide 1Sugars 1Spironolactone 1Qsymia 1Pyruvic Acid 1Pulse Wave Analysis 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Phentermine 1Pancreaticoduodenectomy 1Orchiectomy 1Naltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Metabolic Syndrome × Qsymia × Clear all
NCT05756764 2025-09-09

Anti-obesity Pharmacotherapy and Inflammation

Louisiana State University Health Sciences Center in New Orleans

Active not recruiting
30 enrolled
Other

Inflammation, Obesity, Metabolic Syndrome, Dyslipidemias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡